Characterization of a Clinical Subpopulation With Autism Spectrum Disorder

NCT04273087 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 236

Last updated 2022-11-18

No results posted yet for this study

Summary

The main objective for this research study is to gather additional information to help confirm identification of new subgroups within the autism spectrum.

Conditions

Interventions

OTHER

Observation

Clinical signs and symptoms

Sponsors & Collaborators

  • Stalicla SA

    lead INDUSTRY

Principal Investigators

  • Craig A Erickson, MD · CCHMC

Eligibility

Min Age
10 Years
Max Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-06-04
Primary Completion
2022-10-31
Completion
2022-10-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04273087 on ClinicalTrials.gov